BENITIONSClinical Trial Intelligence

Specific Electrophenotypes in Atrial Fibrillation

단계 해당 없음 조기 종료 NCT05366530

대상 질환Atrial Fibrillation
임상 단계단계 해당 없음
스폰서Imperial College London
상태조기 종료
참여자 수1 명
중재(약물)Biomarkers, electrocardiographic imaging, intracardiac electrograms, cardiac magnetic resonance imaging
시작일2022년 5월 19일
완료일2024년 8월 27일
결과 공개일2026년 3월 12일

요약

This study will investigate a common heart rhythm disturbance (arrhythmia), atrial fibrillation (AF), to improve understanding of how best to treat it in different patients. Direct current cardioversion (DCCV) is a procedure that can revert the heart to a normal rhythm, however almost all patients will only have a transient benefit, and their heart will return to the abnormal rhythm, AF. Ablation is an invasive procedure that creates scar tissue within the heart to reduce the arrhythmias, with a longer lasting effect than DCCV. It has been used with success in AF that occurs occasionally (paroxysmal) but is not as effective in AF that is more long-lasting, also known as persistent AF. Persistent AF is major cause of symptoms of breathlessness and palpitations and significantly increases the risk of stroke. Doctors are unable to accurately predict which patients will benefit most from an ablation, this can lead to as many as 50% of patients not benefitting from the procedure. The aim is to better predict which patients will benefit from an ablation. The study will include patients undergoing AF ablation or DCCV and perform additional tests including blood tests a heart MRI scan, a s

Freedom From Atrial Fibrillation

1 year

BENITIONS에서 보기 ClinicalTrials.gov 원문 보기

같은 질환의 다른 임상

전체 임상

이 페이지는 ClinicalTrials.gov의 공개 데이터를 정리한 것입니다. 의학적 조언이 아니며 투자 권유나 자문도 아닙니다. 반드시 전문의와 상담하세요.